Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.
about
Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Cost-effectiveness of lobectom ...... ing the costs of surveillance.
@en
Cost-effectiveness of lobectomy versus genetic testing
@nl
type
label
Cost-effectiveness of lobectom ...... ing the costs of surveillance.
@en
Cost-effectiveness of lobectomy versus genetic testing
@nl
prefLabel
Cost-effectiveness of lobectom ...... ing the costs of surveillance.
@en
Cost-effectiveness of lobectomy versus genetic testing
@nl
P2860
P1433
P1476
Cost-effectiveness of lobectom ...... ring the costs of surveillance
@en
P2093
Courtney J Balentine
David F Schneider
P2860
P356
10.1016/J.SURG.2017.10.004
P407
P577
2017-11-08T00:00:00Z